![](https://scx1.b-cdn.net/csz/news/tmb/2018/7-studyfindsth.jpg)
Study finds that DFMO increases survival for children with high risk neuroblastoma
A paper published September 27 in Scientific Reports shows the positive results of a phase II clinical trial using the oral medication DFMO to prevent relapse in children with High Risk Neuroblastoma (HRNB).
Oct 1, 2018
0
0